Skip to main content
Log in

Anemia and porphyria caused by N,N′-methylene-bis-acrylamide (MBA) in Mice and rats

  • Original Investigations
  • Published:
Archives of Toxicology Aims and scope Submit manuscript

Abstract

The effects of N,N′-methylene-bis-acrylamide (MBA), a cross-linking agent, on blood and bone marrow after repeated oral doses, were studied in mice and rats. Body weight, three major elements of the blood — erythrocytes, leucocytes and platelets — reticulocytes and bone marrow cells, were all reduced in either or both animals, especially in mice. Phenobarbital (PB) treatment did not greatly modify the effects of MBA in mice. An increase in free erythrocyte porphyrins and a decrease in ALA-D activity were observed in both animals. Urinary porphyrins were elevated in rats after MBA-dosing. PB-treatment did not significantly affect the elevation of porphyrins. After cessation of the MBA-dosing, all these changes were inclined to be restored to normal levels. Amounts of liver total porphyrins and microsomal P-450, and red cell fragility were within normal ranges in mice.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Abbritti G, De Matteis F (1971/72) Decreased levels of cytochrome P-450 and catalase in hepatic porphyria caused by substituted acetamide and barbiturates. Importance of the allyl group molecule of the active drugs. Chem Biol Interact 4: 281–286

    Google Scholar 

  • Askevold R (1951) Routine analysis of porphyrines in urine. Scand J Clin Lab Invest 3: 318–319

    Google Scholar 

  • Dacie JV, Lewis SM (1975) Osmotic fragility. In: Dacie JV, Lewis SM (eds) Practical hematology. Churchill Livingstone, Edinburgh London New York, pp 202–208

    Google Scholar 

  • Dalton PB (1952) Polymers of methylenebis(methacrylamide) and its reaction products. Chem Abstr 46: 1809

    Google Scholar 

  • Davis LN, Durkin PR, Howard PH, Saxena J (1976) Physical and chemical data. In: Davis LN, Durkin PR, Howara PH, Saxena J (eeds) Investigation of selected potential environmental contaminants. Acrylamide. Environmental Protection Agency, Washington, DC, pp 1–18

    Google Scholar 

  • De Bruin A (1976) Dyshematopoiesis and porphyria. In: De Bruin A (ed) Biochemical toxicology of environmental agents. Elsevier, Amsterdam New York, pp 1221–1257

    Google Scholar 

  • Edwards PM (1975) The distribution and metabolism of acrylamide and its neurotoxic analogues in rats. Biochem Pharmacol 24: 1277–1282

    Google Scholar 

  • Gibson KD, Neuberger A, Scott JJ (1955) The purification and properties ofδ-aminolevulinic acid dehydrase. Biochem J 61: 618–629

    Google Scholar 

  • Hashimoto K, Aldridge WN (1970) Biochemical studies on acrylamide. A neurotoxic agent. Biochem Pharmacol 19: 2591–2604

    Google Scholar 

  • Hashimoto K, Sakamoto J, Tanii H (1981) Neurotoxicity of acrylamide and related compounds and their effects on male gonads in mice. Arch Toxicol 47: 179–189

    Google Scholar 

  • Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193: 265–275

    Google Scholar 

  • Malten KE, Van der Meer-Roosen CH, Seutter E (1978) Nyloprint-sensitive patients react to NN′ methylene bis acrylamide. Contact Dermatitis 4: 214–222

    Google Scholar 

  • Nikkanen J, Hernberg S, Tola S (1972) Modifications of theδ-aminolevulinic acid dehydrase test and their significance for assessing different intensities of blood lead exposure. Work Environ Health 9: 46–52

    Google Scholar 

  • Omura T, Sato R (1964) The carbon monoxide-binding pigment of liver microsomes, I. Evidence for its hemoprotein nature. J Biol Chem 239: 2370–2378

    Google Scholar 

  • Piomelli S (1973) A micromethod for free erythrocyte porphyrins: The FEP test. J Lab Clin Med 81: 932–940

    Google Scholar 

  • Pisciotta AV (1971) Drug-induced leucopenia and aplastic anemia. Clin Pharmacol Ther 12: 13–43

    Google Scholar 

  • Schotman P, Gipon L, Jennekens FGI, Gipsen WH (1978) Polyneuropathies and CNS protein metabolism III. Changes in protein synthesis rate induced by acrylamice intoxication. J Neuropathol Exp Neurol 37: 820–837

    Google Scholar 

  • Tomcufcik AS, Willson SD, Vogel AW, Sloboda A (1961) N,N′-alkylene-bis(acrylamides), N(acrylamidomethyl)-3-halopropionamides and related compounds: a new series of antitumor agents. Nature 191: 611–612

    Google Scholar 

  • Tomokuni K, Ogata M (1972) Simple method for determination of urinaryδ-aminolevulinic acid as an index of lead exposure. Clin Chem 18: 1534–1536

    Google Scholar 

  • Wadron HA, Stofen D (1974) Pathological effects of lead. In: Wadron HA, Stofen D (eds) Sub-clinical lead poisoning. Academic Press, London New York, p 82

    Google Scholar 

  • Wintrobe MM, Lee GR, Boggs DR, Bithell TC, Athens JW, Foerster J (1974) Aplastic anemia. In: Wintrobe MM (ed) Clinical hematology. Lea Febiger, Igaku Shoin, Philadelphia Tokyo, pp 1744–1755

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hashimoto, K., Sakamoto, J. Anemia and porphyria caused by N,N′-methylene-bis-acrylamide (MBA) in Mice and rats. Arch Toxicol 50, 47–55 (1982). https://doi.org/10.1007/BF00569236

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00569236

Key words

Navigation